Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with more than 20 years? experience providing outstanding quality and reliability. Our facilities in the US, Europe, and Asia allow us to supply patients worldwide with life-changing therapies. Mission:?To commit our experience to our clients, by providing global manufacturing services, development solutions, and technologies for cell and gene therapies to improve society?s well-being
201 to 500
TypeSubsidiary or Business Segment
Revenue$50 to $100 million (USD) per year
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded1999